Table 5.
Mosquito species | Dosage | Landing experimenta | Biting experimentb | IRR landing vs biting | |||||
---|---|---|---|---|---|---|---|---|---|
IRR (95% CI) | P-value | %PE (1-1RR) | IRR (95% CI) | P-value | %PE (1-1RR) | IRR (95% CI) | P-value | ||
Overall | Overall | 0.87 (0.81–0.93) | < 0.001 | ||||||
Control | 0.90 (0.82–0.97) | 0.01 | |||||||
Transfluthrin | 0.82 (0.74–0.91) | < 0.001 | |||||||
Anopheles gambiae (Ifakara strain) | 0 g | 1.00 | 1.00 | 1 | |||||
5 g | 0.65 (0.47–0.88) | 0.01 | 35 | 0.60 (0.44–0.82) | 0.01 | 40 | 0.77 (0.63–0.94) | 0.01 | |
10 g | 0.55 (0.40–0.72) | 0.01 | 45 | 0.46 (0.33–0.66) | 0.01 | 34 | |||
15 g | 0.52 (0.38–0.72) | 0.01 | 48 | 0.51 (0.36–0.74) | 0.01 | 49 | |||
20 g | 0.41 (0.28–0.61) | 0.01 | 59 | 0.31 (0.11–0.51) | 0.01 | 69 | |||
Anopheles gambiae (Kisumu strain; KDR) | 0 | 1.00 | 1.00 | 1 | |||||
5 g | 0.56 (0.41–0.77) | 0.01 | 44 | 0.68 (0.50–0.93) | 0.01 | 32 | 0.97 (0.80–1.17) | > 0.05 | |
10 g | 0.59 (0.43–0.81) | 0.01 | 41 | 0.57 (0.41–0.81) | 0.01 | 43 | |||
15 g | 0.46 (0.32–0.65) | 0.01 | 54 | 0.48 (0.34–0.69) | 0.01 | 52 | |||
20 g | 0.44 (0.32–0.64) | 0.01 | 56 | 0.46 (0.31–0.69) | 0.01 | 54 | |||
Anopheles funestus | 0 | 1.00 | 1.00 | 1 | |||||
5 g | 0.76 (0.57–1.00) | 0.01 | 34 | 0.70 (0.53–0.95) | 0.01 | 30 | 0.75 (0.63–0.89) | < 0.001 | |
10 g | 0.70 (0.52–0.92) | 0.01 | 30 | 0.56 (0.40–0.77) | 0.01 | 44 | |||
15 g | 0.68 (0.50–0.90) | 0.01 | 32 | 0.50 (0.36–0.69) | 0.01 | 50 | |||
20 g | 0.43 (0.30–0.62) | 0.01 | 57 | 0.40 (0.26–0.60) | 0.01 | 60 |
Incidence rate ratio (IRR) was adjusted for temperature, humidity, volunteer, and compartment
CI Confidence interval
aEstimated by comparison between the treatment and the control for each dose of transfluthrin used in the HLC method
bEstimated using the model comparing the transfluthrin treatment and control for the biting method, in which the mosquitoes were allowed to interact with the human volunteers and blood-feed